AXSM - Axsome Therapeutics GAAP EPS of -$1.32 misses by $0.09 revenue of $57.79M beats by $2.93M
2023-11-06 07:02:58 ET
More on Axsome Therapeutics
- Axsome Update: Buy At Dips And Hold Forever
- Axsome: Beyond The Numbers - Q2 Earnings Sparkle And A Pipeline Full Of Promise
- Mizuho says market fears for Harmony's Wakix drug are "overblown"
- Seeking Alpha’s Quant Rating on Axsome Therapeutics
For further details see:
Axsome Therapeutics GAAP EPS of -$1.32 misses by $0.09, revenue of $57.79M beats by $2.93M